These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 18382149)

  • 1. [Pharmacological rationale for choice of antibiotics for intraabdominal infections].
    Mazzei T; Novelli A
    Infez Med; 2008 Feb; 16 Suppl 1():31-45. PubMed ID: 18382149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological rationale for antibiotic treatment of intra-abdominal infections.
    Mazzei T; Novelli A
    J Chemother; 2009 Jul; 21 Suppl 1():19-29. PubMed ID: 19622447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pharmacodynamic and pharmacokinetic of antibiotics for treatment of skin and soft tissue infections].
    Mazzei T; Novelli A; Arrigucci S
    Infez Med; 2009 Sep; 17 Suppl 4():37-57. PubMed ID: 20428019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of tigecycline, linezolid and vancomycin on biofilms of viridans streptococci isolates from patients with endocarditis.
    Presterl E; Lassnigg A; Eder M; Reichmann S; Hirschl AM; Graninger W
    Int J Artif Organs; 2007 Sep; 30(9):798-804. PubMed ID: 17918125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Therapeutic perspectives of linezolid in the management of infections due to multiresistant Gram-positive pathogens].
    Manfredi R
    Recenti Prog Med; 2007 Mar; 98(3):143-54. PubMed ID: 17484159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What do the new antimicrobials offer? Weighing the advantages and disadvantages compared with traditional agents.
    Gleckman R
    Postgrad Med; 2001 Mar; 109(3):87-91; quiz 28. PubMed ID: 11265366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Guidelines for antimicrobial treatment of the infection by Staphylococcus aureus].
    Mensa J; Soriano A; Llinares P; Barberán J; Montejo M; Salavert M; Alvarez-Rocha L; Maseda E; Moreno A; Pasquau J; Gómez J; Parra J; Candel F; Azanza JR; García JE; Marco F; Soy D; Grau S; Arias J; Fortún J; de Alarcón CA; Picazo J; ; ;
    Rev Esp Quimioter; 2013 Jan; 26 Suppl 1():1-84. PubMed ID: 23824510
    [No Abstract]   [Full Text] [Related]  

  • 8. Impact of Enterococcus faecalis on the bactericidal activities of arbekacin, daptomycin, linezolid, and tigecycline against methicillin-resistant Staphylococcus aureus in a mixed-pathogen pharmacodynamic model.
    LaPlante KL; Rybak MJ; Leuthner KD; Chin JN
    Antimicrob Agents Chemother; 2006 Apr; 50(4):1298-303. PubMed ID: 16569844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary retroperitoneal abscesses due to Rhodococcus equi in a patient with severe nephrotic syndrome: successful antibiotic treatment with linezolid and tigecycline.
    Russo G; Lichtner M; Carnevalini M; Mascellino MT; Mengoni F; Oliva A; Miccoli GA; Iannetta M; Trinchieri V; Massetti AP; Mastroianni CM; Vullo V
    Int J Infect Dis; 2010 Jun; 14(6):e533-5. PubMed ID: 19758832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment options for vancomycin-resistant enterococcal infections.
    Linden PK
    Drugs; 2002; 62(3):425-41. PubMed ID: 11827558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An update on the management of urinary tract infections in the era of antimicrobial resistance.
    Bader MS; Loeb M; Brooks AA
    Postgrad Med; 2017 Mar; 129(2):242-258. PubMed ID: 27712137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [New options for treatment of intraabdominal infections: tigecycline].
    Menichetti F
    Infez Med; 2008 Feb; 16 Suppl 1():53-6. PubMed ID: 18382151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Basic pharmacodynamics of antibacterials with clinical applications to the use of beta-lactams, glycopeptides, and linezolid.
    Craig WA
    Infect Dis Clin North Am; 2003 Sep; 17(3):479-501. PubMed ID: 14711073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro efficacy of antimicrobial agents against high-inoculum or biofilm-embedded meticillin-resistant Staphylococcus aureus with vancomycin minimal inhibitory concentrations equal to 2 μg/mL (VA2-MRSA).
    Tang HJ; Chen CC; Ko WC; Yu WL; Chiang SR; Chuang YC
    Int J Antimicrob Agents; 2011 Jul; 38(1):46-51. PubMed ID: 21549575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Update on antimicrobial chemotherapy].
    Cattoir V; Daurel C
    Med Mal Infect; 2010 Mar; 40(3):135-54. PubMed ID: 19959306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical pharmacokinetic/pharmacodynamic profile of linezolid in severely ill intensive care unit patients.
    Dong H; Wang X; Dong Y; Lei J; Li H; You H; Wang M; Xing J; Sun J; Zhu H
    Int J Antimicrob Agents; 2011 Oct; 38(4):296-300. PubMed ID: 21741222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro efficacy and pharmacodynamic indices for antibiotics against coagulase-negative staphylococcus endophthalmitis isolates.
    Harper T; Miller D; Flynn HW
    Ophthalmology; 2007 May; 114(5):871-5. PubMed ID: 17383732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimal antibiotic dosing. The pharmacokinetic-pharmacodynamic interface.
    Reed MD
    Postgrad Med; 2000 Dec; 108(7 Suppl Contemporaty):17-24. PubMed ID: 19667545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Staphylococcus aureus and antibiotic resistance].
    Sancak B
    Mikrobiyol Bul; 2011 Jul; 45(3):565-76. PubMed ID: 21935792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Therapy of SSTI and role of tigecycline].
    Concia E
    Infez Med; 2009 Sep; 17 Suppl 4():64-76. PubMed ID: 20428022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.